abx-002
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2022 (NCT05528315)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
CNC(=O)COc1cc(Cl)c(Cc2ccc(O)c(C(C)C)c2)c(Cl)c1- Mol. weight
- 382.29 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314909 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06869187 | Phase 2 | Feb 28, 2025 | Autobahn Therapeutics, Inc. |
| NCT06633016 | Phase 2 | Sep 20, 2024 | Autobahn Therapeutics, Inc. |
| NCT05528315 | Phase 1 | Nov 30, 2022 | Autobahn Therapeutics, Inc., Novotech |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Autobahn Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2022 |
| Novotech | For profit | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1